NEW YORK (GenomeWeb News) – The US Food and Drug Administration has granted 510(k) clearance to Quidel's Molecular Influenza A+B and RSV+hMPV assays for use on Life Technologies' QuantStudio Dx Real-Time PCR instrument, the companies said today.
IntelligentMDx said this week that the US Food and Drug Administration has cleared the company's automated molecular diagnostic test for influenza A, influenza B, and respiratory syncytial virus for use on the Abbott m2000 platform.
Alere President and CEO Ron Zwanziger last week provided investors with an update on the development timeline for a pair of point-of-care nucleic acid testing plartforms, the company's first molecular diagnostics products.
NEW YORK (GenomeWeb News) – The US Department of Defense has granted investigators at the University of Washington and their partners $9.6 million to support the development of a paper-based molecular diagnostic testing system that could be used in remote regions and in homes around the world by
Cepheid's Xpert CT/NG assay for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae, launched in the US at the start of the year, has seen the greatest uptake of any new Xpert test since Xpert MRSA, President and CEO John Bishop
Health management services and diagnostics firm Alere recently updated investors on the progress of a pair of nucleic acid testing platforms that are currently under development at the company and represent the firm's entrée into molecular diagnostics.
Nanobiosys, a four-year-old South Korean molecular diagnostics firm, has published the first description and validation study of its flagship technology, a fast, portable, and inexpensive fluidic chip-based real-time PCR instrument.